FDA approves first ALS treatment in more than two decades

(Reuters) - The Food and Drug Administration on Friday approved Mitsubishi Tanabe Pharma Corp's treatment for fatal neurological disorder amyotrophic lateral sclerosis (ALS), marking the first such U.S. regulatory approval in more than two decades.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news